SK Biopharmaceuticals Co., Ltd. (326030.KS) Financials

326030.KS Assets vs Liabilities
DateAssetsLiabilities
Dec. 31, 2025 ? ?
Sept. 30, 2025 1.0 trillion 340.5 billion
June 30, 2025 952.8 billion 338.7 billion
March 31, 2025 1.0 trillion 410.6 billion

326030.KS Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Dec. 31, 2025 ? ?
Sept. 30, 2025 64.1 billion 1.7 billion
June 30, 2025 -4.6 billion -940.1 million
March 31, 2025 27.2 billion -815.8 million

326030.KS Net Income

No data available :(

326030.KS Cash and Debt
Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Dec. 31, 2025 - - -
Sept. 30, 2025 256.2 billion 41.1 billion 49.4 billion
June 30, 2025 222.6 billion 83.9 billion 50.0 billion
March 31, 2025 268.7 billion 84.6 billion 49.7 billion

326030.KS Shares Outstanding
Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Dec. 31, 2025 ?
Sept. 30, 2025 78.3 million
June 30, 2025 78.3 million
March 31, 2025 78.3 million

326030.KS Expenses
Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Dec. 31, 2025 - - - -
Sept. 30, 2025 1.3 billion 40.9 billion 38.8 billion 19.1 billion
June 30, 2025 1.2 billion 39.6 billion 32.2 billion 14.6 billion
March 31, 2025 118.3 million 42.0 billion 60.8 billion 15.9 billion

326030.KS Cost of Revenue
Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Dec. 31, 2025 194.4 billion -
Sept. 30, 2025 191.7 billion 10.3 billion
June 30, 2025 176.3 billion 9.9 billion
March 31, 2025 144.4 billion 10.5 billion

326030.KS

Price: ₩88,100

52 week price:
86900.00
144100.00

Exchange: KSC

Sector: Healthcare

Industry: Biotechnology

Market Capitalization: 8.1 trillion

Links: